Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose (Q81013987)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 2004

Language	Label	Description	Also known as
English	Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose	scientific article published on 01 December 2004

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

phase I clinical trial

1 reference

based on heuristic

inferred from title

author name string

Joseph F Contrera

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Edwin J Matthews

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Naomi L Kruhlak

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

R Daniel Benz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 December 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Regulatory Toxicology and Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

40

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

185-206

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Describing the validity of carcinogen screening tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Genetic algorithms: principles of natural selection applied to computation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Issues in representation of molecular structure the development of molecular connectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Man versus beast: pharmacokinetic scaling in mammals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Concordance of the toxicity of pharmaceuticals in humans and in animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Interspecific Scaling of Toxicity Data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Interspecies extrapolation: a reexamination of acute toxicity data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2004.08.004

7 January 2021

Identifiers

10.1016/J.YRTPH.2004.08.004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15546675%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81013987&oldid=1751088613"